Case Study:  Results from Largest FDA-Funded Intraocular Study on Pediatric Patients with Cataracts

The FDA Awarded the American Academy of Ophthalmology and Verana Health Grant Funding to Analyze the Safety and Outcomes of Intraocular Lens (IOL) Use Among Pediatric Patients with Cataracts.  

Access a copy of the case study to learn how real-world data helped:

• Identify this unique patient population.

• Target the most commonly used IOL brand and model.

• Determine the most frequent adverse event.

   

“This study represents a pivotal step in understanding the challenges faced by a unique population of pediatric patients afflicted with cataracts.”

~Malvina Eydelman, Director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices in the Office of Product Evaluation and Quality within the FDA’s Center for Devices and Radiological Health (CDRH)

Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.